TrialThe oncologist2025

Phase Ib/II trial of talimogene laherparepvec alone and with pembrolizumab in advanced solid tumors with liver metastases and hepatocellular carcinoma.

Joel Randolph Hecht et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.